Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clostridium Histolyticum Collagenase Injection Treatment for Urethral Disease: a Prospective, Single-center, Open-label Study

NCT02948842 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT02948842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02948842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clostridium Histolyticum Collagenase Injection Treatment for Urethral Disease: a Prospective, Single-center, Open-label Study
Lead sponsor
University of South Florida
Phase
Phase 2
Overall status
Completed
Start date
May 22, 2020
Completion date
April 12, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urethral stricture